-
Hi! Welcome to Gender Analysis, a web series offering an in-depth look at transgender issues in society. We're Zinnia Jones and Heather McNamara, and we're the Gender Analysis team!
Featured Post
Depersonalization in gender dysphoria: widespread and widely unrecognized
It’s a sense of unreality, estrangement from your own feelings, and separation from the real world – and it’s a common symptom of gender dysphoria.Support the Blog
-
Recent Posts
- “Still dreaming of running over the trans activists”: Sharon Beck, leader of anti-trans parent group Cardinal Support Network and wife of SEGM’s cofounder, “guided” Ohio Rep. Gary Click on his trans care ban
- Counterpoint: Ohio trans youth care ban veto was a victory for a gatekeeping surveillance state targeting trans adults
- New trial exhibits in Doe v. Ladapo: DOH worked with Genspect leaders Stella O’Malley and Joe Burgo in July 2022; Hilary Cass met SEGM’s Patrick Hunter to discuss Florida’s anti-trans report; Jamie Reed’s attorney Vernadette Broyles chose the lineup of detransitioners speaking at the Board of Medicine
- The Observer gets it wrong: Anti-gay and anti-trans conversion practices have always appealed to “fluidity” of both sexual orientation and gender identity
- Mask off, mask on: Kathleen Goonan, advisor to SEGM and Genspect, taught Moms for Liberty to “play a dual game” and pretend to support parents who accept their trans kids. Then she pretended to support these parents on a podcast with Genspect’s founder.
Topics
- Academia (1)
- Adult care restrictions (2)
- American College of Pediatricians (5)
- Anti-trans detransitioners (1)
- Antiandrogens (5)
- Are You Asking Why? Collective (1)
- Autism (5)
- Awareness building (14)
- Bathrooms and public accommodations (12)
- Biology of transition (23)
- Book reviews (7)
- Breast (15)
- Cardinal Support Network (1)
- Catholic Church (10)
- Catholic Medical Association (1)
- CCV (1)
- Community (2)
- Conversion practices (6)
- COVID-19 (12)
- Dekker v. Weida (6)
- Depersonalization (22)
- Dermatology (4)
- Doe v. Ladapo (2)
- EBM (1)
- Endocrinology (69)
- Ethics (30)
- Faith and religion (18)
- Family (9)
- Feminism (6)
- Fertility and reproduction (7)
- Florida (16)
- Gary Click (1)
- Gatekeeping (2)
- Gender Analysis (4)
- Gender dysphoria (66)
- Gender Exploratory Therapy Association (4)
- Genetics (1)
- Genspect (5)
- Health care (49)
- Heritage Foundation (2)
- History (19)
- HIV/AIDS (2)
- Hoaxes (45)
- Influence groups (6)
- Informed consent (1)
- Law (8)
- Litigation (1)
- Media (46)
- Methodology (1)
- Military (2)
- Misinformation (3)
- Moms for Liberty (1)
- More Trans (4)
- National Catholic Bioethics Center (1)
- News (24)
- Nonbinary (8)
- Ohio (2)
- Ohio administrative rules (2)
- Oncology (15)
- Outcomes of transition (50)
- Parents of ROGD Kids (1)
- Parents of ROGD Kids Ohio (1)
- Perception and cognitive science (3)
- Personal (32)
- Philosophy and language (16)
- Politics (5)
- Politics and law (40)
- Privacy (1)
- Progestogens (11)
- Psychology and psychiatry (36)
- Psychotherapy (2)
- Rapid onset gender dysphoria (3)
- Regret and detransition (21)
- Replies (31)
- Rhetoric (12)
- Right wing (2)
- Safety data (4)
- SB 254 (2)
- Schools (1)
- SEGM (5)
- Sexuality (26)
- Sharon Beck (1)
- Sociological research (28)
- Statistics and demographics (28)
- Stephen Beck (1)
- Surgery (22)
- Surveillance (1)
- TERFs (1)
- Trans youth (98)
- Transfeminine (12)
- Transgender medicine (94)
- Transmasculine (16)
- Transphobia and prejudice (150)
- Uncategorized (13)
- Voice (2)
Blogroll
- Health Liberation Now!
- Trans Safety Network
- Science-Based Medicine
- Heather McNamara
- Jessica Kant
- Erin Reed
- Assigned Media
- TransLash
- Trans Data Library
- Southern Legal Counsel
- Transfeminine Science
- Stained Glass Woman
- TransAdvocate
- Dara Hoffman-Fox
- Growing Up Transgender
- Mermaids UK
- Center of Excellence for Transgender Health
Archives
Category Archives: Progestogens
Denmark population-wide study confirms association between cyproterone acetate and meningioma risk – and recent users of CPA are disproportionately trans women
Previously: Additional data confirms 10mg of cyproterone acetate (CPA) is effective for testosterone suppression in trans women (June 2021) Disclaimer: I am not a medical professional and this is not medical advice. Since 2018, I’ve been covering emerging findings on … Continue reading
Posted in Antiandrogens, Endocrinology, Oncology, Progestogens, Transfeminine, Transgender medicine
Tagged HRT, medicine, science, transition
Leave a comment
Additional data confirms 10mg of cyproterone acetate (CPA) is effective for testosterone suppression in trans women
Previously: Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk of adverse effects (August 2020) Study of entire French population offers further data on cyproterone acetate and meningioma risk (February 2021) Disclaimer: I … Continue reading
Posted in Antiandrogens, Endocrinology, Oncology, Progestogens, Transgender medicine
Tagged HRT, medicine, transition
Leave a comment
Study of entire French population offers further data on cyproterone acetate and meningioma risk
Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Update on case reports: Cyproterone acetate and meningioma in trans women (November 2018) Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk … Continue reading
Posted in Antiandrogens, Endocrinology, Oncology, Progestogens
Tagged HRT, medicine, transition
Leave a comment
Three-year study examines trans women’s breast development from feminizing HRT
For trans women and transfeminine people who are considering or at the very beginning of feminizing hormone therapy, one of the most common points of concern – and uncertainty – is breast development. How soon will it start, how fast … Continue reading
Posted in Breast, Endocrinology, Outcomes of transition, Progestogens, Transfeminine
Tagged HRT, statistics, transition
Leave a comment
Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk of adverse effects
Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Update on case reports: Cyproterone acetate and meningioma in trans women (November 2018) Disclaimer: I am not a medical professional and this is not medical advice. Cyproterone acetate (CPA) … Continue reading
Posted in Endocrinology, Oncology, Progestogens, Transfeminine, Transgender medicine
Tagged HRT, medicine, science, transition
1 Comment
